182 related articles for article (PubMed ID: 2106389)
1. Growth inhibition of human melanoma tumor xenografts in athymic nude mice by swainsonine.
Dennis JW; Koch K; Yousefi S; VanderElst I
Cancer Res; 1990 Mar; 50(6):1867-72. PubMed ID: 2106389
[TBL] [Abstract][Full Text] [Related]
2. Effects of swainsonine and polyinosinic:polycytidylic acid on murine tumor cell growth and metastasis.
Dennis JW
Cancer Res; 1986 Oct; 46(10):5131-6. PubMed ID: 3093060
[TBL] [Abstract][Full Text] [Related]
3. FCE 27266, a sulfonic distamycin derivative, inhibits experimental and spontaneous lung and liver metastasis.
Sola F; Farao M; Ciomei M; Pastori A; Mongelli N; Grandi M
Invasion Metastasis; 1995; 15(5-6):222-31. PubMed ID: 8765197
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of experimental metastasis by castanospermine in mice: blockage of two distinct stages of tumor colonization by oligosaccharide processing inhibitors.
Humphries MJ; Matsumoto K; White SL; Olden K
Cancer Res; 1986 Oct; 46(10):5215-22. PubMed ID: 3093061
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of growth of subcutaneous xenografts and metastasis of human breast carcinoma by swainsonine: modulation of tumor cell HLA class I antigens and host immune effector mechanisms.
Mohla S; White S; Grzegorzewski K; Nielsen D; Dunston G; Dickson L; Cha JK; Asseffa A; Olden K
Anticancer Res; 1990; 10(6):1515-22. PubMed ID: 2126682
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of N-linked oligosaccharide processing in tumor cells is associated with enhanced tissue inhibitor of metalloproteinases (TIMP) gene expression.
Korczak B; Dennis JW
Int J Cancer; 1993 Feb; 53(4):634-9. PubMed ID: 8436437
[TBL] [Abstract][Full Text] [Related]
7. Preclinical antitumor efficacy of the polyamine analogue N1, N11-diethylnorspermine administered by multiple injection or continuous infusion.
Bernacki RJ; Oberman EJ; Seweryniak KE; Atwood A; Bergeron RJ; Porter CW
Clin Cancer Res; 1995 Aug; 1(8):847-57. PubMed ID: 9816054
[TBL] [Abstract][Full Text] [Related]
8. Lupeol inhibits growth of highly aggressive human metastatic melanoma cells in vitro and in vivo by inducing apoptosis.
Saleem M; Maddodi N; Abu Zaid M; Khan N; bin Hafeez B; Asim M; Suh Y; Yun JM; Setaluri V; Mukhtar H
Clin Cancer Res; 2008 Apr; 14(7):2119-27. PubMed ID: 18381953
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of human melanoma growth by prostaglandin A, D, and J analogues.
Bregman MD; Funk C; Fukushima M
Cancer Res; 1986 Jun; 46(6):2740-4. PubMed ID: 3698005
[TBL] [Abstract][Full Text] [Related]
10. N-linked oligosaccharide processing and autocrine stimulation of tumor cell proliferation.
VanderElst I; Dennis JW
Exp Cell Res; 1991 Feb; 192(2):612-21. PubMed ID: 1899075
[TBL] [Abstract][Full Text] [Related]
11. Earthworm fibrinolytic enzyme: anti-tumor activity on human hepatoma cells in vitro and in vivo.
Chen H; Takahashi S; Imamura M; Okutani E; Zhang ZG; Chayama K; Chen BA
Chin Med J (Engl); 2007 May; 120(10):898-904. PubMed ID: 17543180
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the antitumor activity of recombinant human gamma-interferon employing human melanoma xenografts in athymic nude mice.
Trotta PP; Harrison SD
Cancer Res; 1987 Oct; 47(20):5347-53. PubMed ID: 3115565
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the tumor vasculature and metastatic behavior of xenografts of human melanoma cell lines transfected with vascular permeability factor.
Pötgens AJ; van Altena MC; Lubsen NH; Ruiter DJ; de Waal RM
Am J Pathol; 1996 Apr; 148(4):1203-17. PubMed ID: 8644861
[TBL] [Abstract][Full Text] [Related]
14. Effects of alpha-difluoromethylornithine and recombinant interferon-alpha 2 on the growth of a human renal cell adenocarcinoma xenograft in nude mice.
Heston WD; Fleischmann J; Tackett RE; Ratliff TL
Cancer Res; 1984 Aug; 44(8):3220-5. PubMed ID: 6430546
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 10 suppresses tumor growth and metastasis of human melanoma cells: potential inhibition of angiogenesis.
Huang S; Xie K; Bucana CD; Ullrich SE; Bar-Eli M
Clin Cancer Res; 1996 Dec; 2(12):1969-79. PubMed ID: 9816156
[TBL] [Abstract][Full Text] [Related]
16. Phase IB clinical trial of the oligosaccharide processing inhibitor swainsonine in patients with advanced malignancies.
Goss PE; Reid CL; Bailey D; Dennis JW
Clin Cancer Res; 1997 Jul; 3(7):1077-86. PubMed ID: 9815786
[TBL] [Abstract][Full Text] [Related]
17. Influence of asparagine-linked oligosaccharides on tumor cell recognition in the mixed lymphocyte reaction.
Powell LD; Bause E; Legler G; Molyneux RJ; Hart GW
J Immunol; 1985 Jul; 135(1):714-24. PubMed ID: 3158709
[TBL] [Abstract][Full Text] [Related]
18. Lack of antitumour activity of human recombinant tumour necrosis factor-alpha, alone or in combination with melphalan in a nude mouse human melanoma xenograft system.
Furrer M; Altermatt HJ; Ris HB; Althaus U; Rüegg C; Liénard D; Lejeune FJ
Melanoma Res; 1997 Aug; 7 Suppl 2():S43-9. PubMed ID: 9578416
[TBL] [Abstract][Full Text] [Related]
19. Fully human antibodies to MCAM/MUC18 inhibit tumor growth and metastasis of human melanoma.
Mills L; Tellez C; Huang S; Baker C; McCarty M; Green L; Gudas JM; Feng X; Bar-Eli M
Cancer Res; 2002 Sep; 62(17):5106-14. PubMed ID: 12208768
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of human breast cancer metastasis in nude mice by synthetic glycoamines.
Glinsky GV; Price JE; Glinsky VV; Mossine VV; Kiriakova G; Metcalf JB
Cancer Res; 1996 Dec; 56(23):5319-24. PubMed ID: 8968076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]